Skip to main content
OpenTrials

Clinical trial condition

Leukemia, T-Cell

Explore clinical trials studying Leukemia, T-Cell. Study availability and eligibility vary by location and protocol.

144 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, T-Cell trial results

Completed

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

NCT05225584

Conditions
Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
Locations
  • UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Hackensack University Medical Center, John Theurer Cancer Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Completed

KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

NCT01626664

Conditions
Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Miami / Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • National Cancer Institute Bethesda, Maryland, United States
View all 20 locations
View Trial Details
Completed

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

NCT02168140

Conditions
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
Locations
  • Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
  • Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

NCT00897767

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +42 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 214 locations
View Trial Details
Completed

A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia

NCT03873493

Conditions
Cancer, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Dana-Farber Cancer Institute /ID# 207728 Boston, Massachusetts, United States
  • Mayo Clinic - Rochester /ID# 207692 Rochester, Minnesota, United States
  • University of Texas MD Anderson Cancer Center /ID# 207746 Houston, Texas, United States
  • Peter MacCallum Cancer Ctr /ID# 209554 Melbourne, Victoria, Australia
View all 15 locations
View Trial Details

Related conditions